Literature DB >> 21233246

Epithelial ovarian cancer.

Robert J Morgan1, Ronald D Alvarez, Deborah K Armstrong, Barry Boston, Robert A Burger, Lee-May Chen, Larry Copeland, Marta Ann Crispens, David Gershenson, Heidi J Gray, Perry W Grigsby, Ardeshir Hakam, Laura J Havrilesky, Carolyn Johnston, Shashikant Lele, Ursula A Matulonis, David M O'Malley, Richard T Penson, Steven W Remmenga, Paul Sabbatini, Russell J Schilder, Julian C Schink, Nelson Teng, Theresa L Werner.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21233246     DOI： 10.6004/jnccn.2011.0008

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  37 in total

1.  Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).

Authors:  Jennifer M Scalici; Sanja Arapovic; Erin J Saks; Kristen A Atkins; Gina Petroni; Linda R Duska; Jill K Slack-Davis
Journal:  Cancer       Date:  2016-11-07       Impact factor: 6.860

Review 2.  Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.

Authors:  Daisuke Kobayashi; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2016-11-01       Impact factor: 7.370

Review 3.  Is It Time to Centralize Ovarian Cancer Care in the United States?

Authors:  Renee A Cowan; Roisin E O'Cearbhaill; Ginger J Gardner; Douglas A Levine; Kara Long Roche; Yukio Sonoda; Oliver Zivanovic; William P Tew; Evis Sala; Yulia Lakhman; Hebert A Vargas Alvarez; Debra M Sarasohn; Svetlana Mironov; Nadeem R Abu-Rustum; Dennis S Chi
Journal:  Ann Surg Oncol       Date:  2015-10-28       Impact factor: 5.344

4.  Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer.

Authors:  Wei Wen; Wei Liang; Jun Wu; Claudia M Kowolik; Ralf Buettner; Anna Scuto; Meng-Yin Hsieh; Hao Hong; Christine E Brown; Stephen J Forman; David Horne; Robert Morgan; Mark Wakabayashi; Thanh H Dellinger; Ernest S Han; John H Yim; Richard Jove
Journal:  Mol Cancer Ther       Date:  2014-10-15       Impact factor: 6.261

5.  Quantitative measurement of adiposity using CT images to predict the benefit of bevacizumab-based chemotherapy in epithelial ovarian cancer patients.

Authors:  Yunzhi Wang; Theresa Thai; Kathleen Moore; Kai Ding; Scott McMeekin; Hong Liu; Bin Zheng
Journal:  Oncol Lett       Date:  2016-05-31       Impact factor: 2.967

Review 6.  Checkpoint inhibitors in immunotherapy of ovarian cancer.

Authors:  Dong-hui Wang; Liang Guo; Xiao-hua Wu
Journal:  Tumour Biol       Date:  2014-11-20

7.  Expression and clinical significance of focal adhesion kinase and adrenomedullin in epithelial ovarian cancer.

Authors:  Mingqun Li; L I Hong; Meimei Liao; Guanglin Guo
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

8.  Mediation analysis of alcohol consumption, DNA methylation, and epithelial ovarian cancer.

Authors:  Dongyan Wu; Haitao Yang; Stacey J Winham; Yanina Natanzon; Devin C Koestler; Tiane Luo; Brooke L Fridley; Ellen L Goode; Yanbo Zhang; Yuehua Cui
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

9.  Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.

Authors:  Melissa Hodeib; Jenny Chang; Fong Liu; Argyrios Ziogas; Sarah Dilley; Leslie M Randall; Hoda Anton-Culver; Robert E Bristow
Journal:  Gynecol Oncol       Date:  2015-04-22       Impact factor: 5.482

10.  Trefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling.

Authors:  Shan Zhao; Yumei Ma; Xianghua Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.